Clinical Significance of Adropin and Salusins Circulating Levels in End-Stage Kidney Disease Patients With Cardiovascular Events
Lashin, Fatma E S; Abdel Hamid, Fatma F; El-Guindy, Amr D M; Soliman, Dalia S; Soliman, Ahmed F;
Abstract
Patients with end-stage kidney disease (ESKD) face a significantly increased risk of cardiovascular disease (CVD). Effective management of these patients necessitates the early identification and continuous monitoring of cardiovascular complications. This study aimed to evaluate the clinical utility of circulating adropin, salusin-α (Sal-α), and salusin-β (Sal-β) levels in ESKD patients, with and without co-occurring CVD.
Other data
| Title | Clinical Significance of Adropin and Salusins Circulating Levels in End-Stage Kidney Disease Patients With Cardiovascular Events | Authors | Lashin, Fatma E S; Abdel Hamid, Fatma F; El-Guindy, Amr D M; Soliman, Dalia S; Soliman, Ahmed F | Keywords | adropin;cardiovascular disease (CVD);end‐stage kidney disease (ESKD);salusin‐α (Sal‐α);salusin‐β (Sal‐β) | Issue Date | 21-Aug-2025 | Journal | Hemodialysis International | DOI | 10.1111/hdi.70023 | PubMed ID | 40842085 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.